AIDS activists, researchers, and service providers are challenging Gilead’s decision to enter into narrow, bilateral voluntary licenses for its long-acting antiretroviral, lenacapavir (LEN-LA), ...

Merck’s agreement with the Medicines Patent Pool (MPP) aims to facilitate affordable global access for molnupiravir. Merck, known as MSD outside of the United States and Canada, announced on Oct. 27, ...

The Medicines Patent Pool (MPP) inked a license and technology transfer agreement with Egyptian drug manufacturer Pharco Pharmaceuticals covering affordable supply of the late-clinical-stage ...

Under the terms of the agreement, MPP, through the license granted by Merck, will be permitted to further license non-exclusive sublicenses to manufacturers (“MPP License”) and diversify the ...

The voluntary licensing agreement reached between ViiV and the Medicines Patent Pool for long-acting cabotegravir has received significant media attention, criticism, and protests because of the ...

March 17 (Reuters) - Thirty five generic drugmakers around the world will make cheap versions of Pfizer Inc's highly effective COVID-19 oral antiviral Paxlovid to supply the treatment in 95 poorer ...

The U.N.'s Medicines Patent Pool (MPP) has signed a variety of sub-license agreements covering generics of four HIV antiretroviral treatments and hepatitis C therapy ...

Granules India has received a license from Medicines Patent Pool MPP to manufacture and market generic versions of Pfizers oral treatment nirmatrelvir which will be copackaged with ritonavir for ...

U.S.-based pharmaceutical giant Merck & Co. said it will license drugmakers worldwide to produce its potentially lifesaving antiviral pill for treatment of COVID-19 in adults. The drug, known as ...

KENILWORTH, N.J.--(BUSINESS WIRE)--The Medicines Patent Pool (MPP) and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the signing of a voluntary licensing ...

KENILWORTH, N.J.--(BUSINESS WIRE)--$MRK #MRK--The Medicines Patent Pool (MPP) and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today ...